Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-009572
Filing Date
2025-05-12
Accepted
2025-05-12 08:15:29
Documents
55
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 632678
2 ex31-1.htm EX-31.1 20535
3 ex31-2.htm EX-31.2 20548
4 ex32-1.htm EX-32.1 8798
  Complete submission text file 0001641172-25-009572.txt   3520008

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE imnn-20250331.xsd EX-101.SCH 27866
6 XBRL CALCULATION FILE imnn-20250331_cal.xml EX-101.CAL 37861
7 XBRL DEFINITION FILE imnn-20250331_def.xml EX-101.DEF 102532
8 XBRL LABEL FILE imnn-20250331_lab.xml EX-101.LAB 294060
9 XBRL PRESENTATION FILE imnn-20250331_pre.xml EX-101.PRE 220875
57 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 371661
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15911 | Film No.: 25932708
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)